SILENCE THERAPEUTICS PLC
Research and experimental development on biotechnology
SILENCE THERAPEUTICS PLC
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
27 Eastcastle Street London W1W 8DH
Full company profile for SILENCE THERAPEUTICS PLC (02992058), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 18 Nov 1994. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2013–2025)
Cash in Bank
£85.11M
Net Assets
£62.30M
Total Liabilities
£69.14M
Turnover
£559.00k
Employees
88
Debt Ratio
53%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 Dec Year End | 2024 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 8 funding rounds
Sign up to view complete fundraising history
Investors (15)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Mar 2020 | Strategic Investment, IPO |
| Investor 10 | Feb 2021 | IPO |
| Investor 13 | Feb 2021 | IPO |
See all 15 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Rhonda Hellums | Secretary | Unknown | Unknown | 26 Jan 2024 | Active |
See all 67 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Richard Ian Griffiths
British
- Ownership Of Shares 25 To 50 Percent
Richard Ian Griffiths
Ceased 30 Nov 2021
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 9 Jan 2026 | Officers | Appointment of Ms Rhonda Hellums as director on 2025-12-18 | |
| 8 Jan 2026 | Officers | Appointment of Mr James Lawrence Ede-Golightly as director on 2025-12-14 | |
| 6 Jan 2026 | Officers | Termination of Craig Tooman as director on 2025-12-14 | |
| 20 Aug 2025 | Persons With Significant Control | Withdrawal Of A Person With Significant Control Statement | |
| 20 Aug 2025 | Capital | Allotment of shares (GBP 7,085,092.4) on 2025-05-30 |
Appointment of Ms Rhonda Hellums as director on 2025-12-18
Appointment of Mr James Lawrence Ede-Golightly as director on 2025-12-14
Termination of Craig Tooman as director on 2025-12-14
Withdrawal Of A Person With Significant Control Statement
Allotment of shares (GBP 7,085,092.4) on 2025-05-30
Recent Activity
Latest Activity
Appointment of Ms Rhonda Hellums as director on 2025-12-18
3 months ago on 9 Jan 2026
Appointment of Mr James Lawrence Ede-Golightly as director on 2025-12-14
3 months ago on 8 Jan 2026
Termination of Craig Tooman as director on 2025-12-14
3 months ago on 6 Jan 2026
Withdrawal Of A Person With Significant Control Statement
8 months ago on 20 Aug 2025
Allotment of shares (GBP 7,085,092.4) on 2025-05-30
8 months ago on 20 Aug 2025